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Research
The REACT study: randomised evaluation of assertive community
treatment in north London
Helen Killaspy, Paul Bebbington, Robert Blizard, Sonia Johnson, Fiona Nolan, Stephen Pilling, Michael King
Abstract
Objective To compare outcomes of care from assertive
community treatment teams with care by community mental
health teams for people with serious mental illnesses.
Design Non-blind randomised controlled trial.
Setting Two inner London boroughs.
Participants 251 men and women under the care of adult
secondary mental health services with recent high use of
inpatient care and difficulties engaging with community
services.
Interventions Treatment from assertive community treatment
team (127 participants) or continuation of care from
community mental health team (124 participants).
Main outcome measures Primary outcome was inpatient bed
use 18 months after randomisation. Secondary outcomes
included symptoms, social function, client satisfaction, and
engagement with services.
Results No significant differences were found in inpatient bed
use (median difference 1, 95% confidence interval − 16 to 38)
or in clinical or social outcomes for the two treatment groups.
Clients who received care from the assertive community
treatment team seemed better engaged (adapted homeless
engagement acceptance schedule: difference in means 1.1, 1.0
to 1.9), and those who agreed to be interviewed were more
satisfied with services (adapted client satisfaction questionnaire:
difference in means 7.14, 0.9 to 13.4).
Conclusions Community mental health teams are able to
support people with serious mental illnesses as effectively as
assertive community treatment teams, but assertive community
treatment may be better at engaging clients and may lead to
greater satisfaction with services.
Introduction
Since the 1990s the relocation of mental health services from
hospital to the community has proceeded at a fast pace in Eng-
land. Despite well equipped community mental health teams, the
needs of a substantial subgroup of patients who are severely ill
and difficult to engage with services remain difficult to meet.1
Assertive community treatment originated from Stein and Test’s
model of home based treatment,2 an alternative approach to
admission to psychiatric hospital that was successfully replicated
in Australia3 and gradually evolved into two specific models:
assertive community treatment4 and crisis resolution. Assertive
community treatment has gained popularity for service users
who have problems engaging with services but for whom psychi-
atric care is essential. Systematic reviews concluded that when
targeted at high users of inpatient services, assertive community
treatment reduces the costs of care by decreasing frequency and
length of admissions.5 6 Other positive outcomes include
increased engagement with services, more stability in accommo-
dation, and improved satisfaction for patients and their carers.5
It has been difficult to appraise the efficacy of assertive com-
munity treatment in England and other European countries with
similar service systems. This was because the models of intensive
forms of community care investigated were not based closely on
such treatment and did not focus on participants who were diffi-
cult to engage.7–11 Also, comparison groups in these UK studies
were more community based than those in US trials.12 The
Cochrane review concluded that there was a case for a further
randomised trial of assertive community treatment in the United
Kingdom.5
The equivocal evidence has not prevented the Department of
Health encouraging the implementation of assertive community
treatment as a tertiary model of care. By 2004, 263 such teams
existed in England.13 14 As two teams were being established
within our service, we compared the clinical outcomes and cost
effectiveness of assertive community treatment with standard
treatment from a community mental health team for clients
identified as difficult to engage and who were high users of inpa-
tient care. We hypothesised that assertive community treatment
delivered by specialised teams operating with a high degree of
fidelity to the model would lead to fewer days of inpatient care
than standard case management provided by community mental
health teams. The results of the cost effectiveness analysis are the
topic of a separate paper.
Methods
We carried out the trial in the inner London boroughs of Cam-
den and Islington.High levels of deprivation give this area one of
the highest estimated levels of psychiatric morbidity in the
United Kingdom.15
Participants were referred from the 13 local community
mental health teams and met the following inclusion criteria: liv-
ing in independent or low supported accommodation within the
two boroughs; under the care of the community mental health
team for at least 12 months and identified as having difficulty
engaging with standard community care; primary diagnosis of
serious mental illness (for example, schizophrenia, schizoaffec-
tive disorder, other chronic psychosis, bipolar affective disorder);
and recent high use of inpatient care (at least 100 consecutive
inpatient days or at least five admissions within the past two years
or at least 50 consecutive inpatient days or at least three admis-
sions within the past year). Individuals with concurrent problems
from substance misuse or personality disorder were eligible if
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these were secondary diagnoses. We excluded patients with
organic brain damage.
A panel of clinicians and researchers met each month to
consider referred clients that met all but the inpatient bed day
criteria and whose mental health problems placed them at major
risk from themselves or others despite input from the
community mental health team.
We recruited participants between July 1999 and July 2002.
Ethical issues are raised in the research of assertive community
treatment as such treatment targets patients whose willingness to
engage with services and consent to interventions is limited. A
study group consisting only of participants who consented to
assertive community treatment would therefore have been
highly unrepresentative. The evidence for assertive community
treatment in the United Kingdom is meagre, but the treatment’s
national implementation created the need for a valid trial. The
trial’s conclusions could then be generalised to the client group
that is the focus of such treatment. We obtained approval for
randomisation of all eligible participants whether or not they
consented to referral to assertive community treatment. Only
participants willing to give informed consent were interviewed at
baseline and follow-up. For those who could not be interviewed,
we obtained ethical approval to use data on inpatient bed use
from the local computerised patient record system and for
collection of the main staff rated secondary outcomes.
Recruitment and randomisation
Staff of the community mental health teams were asked to
discuss the trial with clients who met eligibility criteria and to
explain that they would be randomly allocated either to receive
care from the assertive community treatment team or to
continue with the community mental health team for 18 months
(after which they could be taken on by the assertive community
treatment team if still clinically appropriate). HK attempted to
contact each participant to gain informed consent for the base-
line interview. Randomisation took place after the baseline
research assessment to reduce any potential interviewer bias.
Participants who could not be interviewed were randomised
after they refused interview or after three failed attempts to visit
them.
Randomisation was supervised by the trial statistician (RB),
who prepared participants’ numbers for each community mental
health team by permuted block randomisation with a block size
of eight, ensuring parity between community mental health
teams in proportions randomised to assertive community treat-
ment. Participants were randomly allocated to either treatment
on an equal basis. The interviewer contacted an administrator at
the trial centre who opened the appropriate numbered envelope
giving details of the outcome of randomisation. Participants and
referrers were informed of the outcome by letter. The 18 month
assessment period was dated from randomisation. All interviews
were carried out by HK or FN, who were independent of clinical
care but not blind to treatment allocation as data collection
necessitated liaison with care coordinators.
Treatment groups
Participants received care according to nationally recognised
models of assertive community treatment4 16 or community
mental health team practice.17 Local community mental health
teams were well established, with integrated health and social
care professionals. Table 1 summarises the models of care. Fidel-
ity to the model for the assertive community treatment team was
assessed independently through the pan-London assertive
outreach study18 using the Dartmouth assertive community
treatment scale.19 An independent researcher used the same
measure to rate the model fidelity of all 13 community mental
health teams. Model fidelity and content of care received by each
group were investigated using both quantitative and qualitative
methods and will be described elsewhere.
Outcome measures
Diagnosis was confirmed (except for non-consenting partici-
pants) by structured examination of case notes and participant
interviews using a standardised operational criteria checklist.20
The primary outcome was the number of days spent as a mental
health inpatient during the 18 month period. Secondary
outcomes were chosen on the basis of those used in other stud-
ies of assertive community treatment5: satisfaction with services,
using the client satisfaction questionnaire21 modified to include
specific questions about assertive community treatment22; clinical
and social functioning, using the expanded brief psychiatric rat-
ing scale,23 24 health of the nation outcome scales,25 and life skills
profile26; needs assessment, using the abbreviated form of the
Camberwell assessment of needs27; quality of life, using the Man-
chester short assessment of quality of life28; serious incidents
concerning deliberate self harm, violence towards others, and
contact with police or forensic services; engagement with
services from numbers lost to follow-up, and quality of
engagement, using the adapted form of the homeless
engagement acceptance scale29; factors influencing compliance
with medication using the rating of medication influences scale
in schizophrenia30; use of the Mental Health Act; and substance
misuse, using the clinician alcohol and drug scale.31 The
expanded brief psychiatric rating scale,23 24 Camberwell assess-
ment of needs,27 Manchester short assessment of quality of life,28
and adapted client satisfaction questionnaire21 22 were completed
from interviews with clients. The health of the nation outcome
scales,25 life skills profile,26 homeless engagement acceptance
scale,29 rating of medication influences scale,30 and clinician alco-
hol and drug scale31 were completed by care coordinators. All
other data were collected from case notes.
Statistical analysis
An audit before the study informed the calculation of sample
size. This showed that patients meeting criteria for assertive
Table 1 Characteristics of assertive community treatment teams and
community mental health teams
Characteristic
Assertive community treatment
teams16
Community mental health
teams17
Total team case load 80 to 100 300 to 350
Maximum individual case
load
12 35
Availability Extended hours (0800 to 2000
every day)
Office hours only (0900 to
1700 Mon-Fri)
Locations for
appointments
Not office based (“in vivo”): meet
client at home, in cafes, parks,
etc
Office based appointments
and home visits
Contact with clients Assertive engagement: multiple
attempts, flexible and various
approaches (for example,
befriending, offering practical
support, leisure activities)
Offer appointments at office
or make home visits
Commitment to care “No drop-out” policy: continue to
try to engage in long term care
Discharge if unable to make
or maintain contact
Case work style Team approach—all team
members work with all clients
Case management—little
“sharing” of work with clients
between team members
Frequency of team
meetings
Frequent (up to daily) to discuss
clients and daily plans
Weekly
Source of skills Team rather than outside
agencies as far as possible
“Brokerage”: referral to
outside agencies for advice
(for example, social security
benefits, housing)
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community treatment had spent a mean 176 days (SD 169,
median 133) in hospital in the 24 months before the trial began.
Results from the Cochrane review5 showed a difference in dura-
tion of admission of over one third in favour of assertive
community treatment for seven of the 14 randomised controlled
trials that reported this outcome. To have 80% power in our
study for detection of a reduction in mean bed days of one third
required 125 patients in each treatment group. Analysis was on
an intention to treat basis. Owing to non-normally distributed
data, in the primary analysis we used the Mann-Whitney test to
compare the median number of inpatient days over the 18
month study period. We used Hodges-Lehmann estimates to
calculate confidence intervals for the median difference. Partici-
pants who died or emigrated during the study period were
excluded. Observed inpatient days are reported, although a sen-
sitivity analysis was carried out by assigning a pessimistic
outcome (scaling up observed inpatient days to 18 months) to all
patients who were lost to follow-up. This did not substantially
change the results. We compared secondary outcomes using t
tests for normally distributed quantitative data, Mann-Whitney’s
test for non-normally distributed data, and 2 tests for categorical
variables. As analyses adjusted for baseline differences gave simi-
lar results we show only unadjusted results.
Results
Between July 1999 and July 2002 we recruited 251 participants
into the trial (fig 1). Twenty clients who met all the criteria except
for bed days were referred to the panel, 18 of whom were
included in the trial. At baseline, 168 (67%) participants
consented to be interviewed: 90 of 127 (71%) assigned to the
assertive community treatment team and 78 of 124 (63%)
assigned to the community mental health team. Care coordina-
tors were unable to complete baseline assessments for three par-
ticipants (one assigned assertive community treatment, two
assigned community mental health care) who were out of
contact with services at recruitment. Ninety one of the 124 (73%)
participants in the assertive treatment group and 75 of the 119
(63%) in the mental healthcare group who were available at 18
months agreed to the follow-up interview (response rate 68%).
Both interviews were agreed by 73 (57%) participants in the
assertive community treatment group and 56 (45%) in the com-
munity mental health team group.
Participants and teams
The groups had similar characteristics at baseline (table 2). The
median duration of illness was 10 years. The mean number of
previous admissions was eight (half of which were involuntary),
and the median duration was more than two months. Substance
misuse was equally prevalent among clients assigned to assertive
community treatment and to community mental health team
care: illicit drugs, 37 (29%) v 29 (23%); alcohol, 30 (24%) v 32
(26%).
The pan-London assertive outreach study18 rated the model
fidelity of one of the assertive community treatment teams in our
study as high (mean score 4.1 on Dartmouth assertive
community treatment scale19) and the other as “assertive
community treatment-like” (mean score 3.4). The mean for all 24
London assertive community treatment teams included in the
pan-London study was 3.4 (range 2.3 to 4.1) and the mean for
community mental health teams was 2.7 (range 1.9 to 3.2). The
13 community mental health teams in our study had a mean
score of 2.7 on the Dartmouth scale. The mean number of face
to face contacts during the second nine months of the study was
three times greater for participants in the assertive community
treatment group than for those in the community mental health
team group (49 (SD 49) v 16 (SD 23), difference in means 33,
95% confidence interval 22.6 to 42.1; P < 0.001).
Primary outcome
No statistically significant differences were found between the
trial arms in inpatient bed days over the 18 months of follow-up
(median difference 1, − 16 to 38) or in any other indicator of
inpatient service use (fig 2 and table 3).
Secondary outcomes
All ratings of satisfaction were higher for clients assigned to
assertive community treatment, and total satisfaction scores were
significantly greater (effect size 0.35 SD). No statistically
significant differences were found in clinical or social
functioning between groups (table 4). Ratings on the adapted
homeless engagement acceptance scale indicated greater quality
of engagement with services for clients assigned assertive
treatment (effect size 0.29 SD); fewer clients in the assertive com-
munity treatment group were lost to follow-up (defined as out of
contact for over three months) than those in the community
mental health team group. Serious incidents were equally
distributed between the groups. Three clients assigned to
Patients randomised (n=251)
Died within 18 months (n=4)Died within 18 months (n=3)
Assertive community treatment team (n=127):
 Consented to baseline interview (n=90)
Interviewed at 18 months (n=91) Interviewed at 18 months (n=75)
Hospital admission data available at 18
 months (n=124):
  Out of contact (n=0)
Hospital admission data available at 18
 months (n=119):
  Out of contact (n=4)
Community mental health care team (n=124):
 Consented to baseline interview (n=78)
 Out of contact (n=2)
Refused (n=28)
Did not respond (n=16)
Refused (n=23)
Did not respond (n=9)
Emigrated (n=1)
Fig 1 Flow of participants through trial
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community mental health team care and one client assigned to
assertive community treatment committed suicide during the
study period.
Discussion
Our study found no evidence of greater clinical efficacy or
improvement in social outcomes for recipients of assertive com-
munity treatment compared with usual care from community
mental health teams.
Our trial tackled the limitations of previous studies7–10 by
using a randomised controlled design and testing the standard
model for assertive community treatment.4 16 Our assertive com-
munity treatment teams had medium to high model fidelity and
were representative of such teams in London.18 Our referral cri-
teria were strictly adhered to and only a small number of partici-
pants not meeting referral criteria for recent inpatient care were
recruited through our panel. Primary outcome data were
available for all participants. Our findings therefore seem robust
for inner city populations in the United Kingdom.
Table 2 Baseline characteristics of clients with serious mental illness
assigned to assertive community treatment or to community mental health
team care. Values are numbers (percentages) of clients unless stated
otherwise
Characteristics
Assertive community
treatment team (n=127)
Community mental
health team (n=124)
Response to interview:
Consented 90 (71) 78 (63)
Refused 24 (19) 27 (22)
No response 13 (10) 19 (15)
Male 79 (62) 68 (55)
Mean (SD) age (years) 38 (11) 40 (11)
Inpatient at recruitment 60 (47) 55 (44)
Recruited through panel 8 (6) 10 (8)
Unemployed* 81 (90) 68 (87)
Ethnic group:
White 65 (51) 71 (57)
African Caribbean 52 (41) 39 (31)
Other 10 (8) 14 (11)
Diagnosis†:
Schizophrenia 70 (68) 63 (65)
Schizoaffective 18 (17) 15 (15)
Bipolar affective 6 (6) 4 (4)
Delusional disorder 3 (3) 5 (5)
Major depression 0 (0) 2 (2)
Other 6 (6) 8 (8)
Inpatient service use
Length of illness (months):
Mean (SD) 138 (102) 160 (120)
Median (interquartile range) 115 (67-181) 130 (60-237)
No of total admissions:
Mean (SD) 8 (6) 8 (5)
Median (interquartile range) 7 (4-11) 6 (4-11)
No of admissions in past two years:
Mean (SD) 2 (2) 2 (1)
Median (interquartile range) 2 (1-3) 2 (1-3)
No of involuntary admissions†
Mean (SD) 4 (3) 4 (3)
Median (interquartile range) 4 (2-6) 3 (2-6)
No of involuntary admissions in past
two years†
Mean (SD) 2 (1) 2 (1)
Median (interquartile range) 1 (1-2) 2 (1-2)
No of inpatient days per admission
Mean (SD) 95 (71) 92 (63)
Median (interquartile range) 69 (47-120) 76 (51-113)
No of days per admission in past two
years
Mean (SD) 116 (124) 106 (103)
Median (interquartile range) 75 (48-133) 76 (48-127)
Clinical or social function:
Mean (SD) symptoms (EBPRS)* 36.4 (9.1), n=90 36.2 (11.7), n=78
Mean (SD) quality of life (MANSA)* 4.4 (0.9), n=82 4.2 (73), n=73
Mean (SD) unmet needs (CANSAS)* 4.4 (3.1), n=90 5.0 (3.2), n=77
Mean (SD) social function (LSP) 109.9 (16.3), n=126 109.2 (15.9), n=122
Mean (SD) total score (HoNOS) 12.4 (6.6), n=126 13.3 (7.1), n=122
EBPRS=expanded brief psychiatric rating scale; MANSA=Manchester short assessment of
quality of life; CANSAS=Camberwell assessment of needs short assessment schedule;
LSP=life skills profile; HoNOS=health of the nation outcome scales.
*Consented to participate.
†Consented to participate or non-responder.
No of inpatient days
No
 o
f c
lie
nt
s
0
10
15
20
25
30
5
0
Assertive community treatment team
Community mental health care team
50 100 150 200 250 300 350 400 450 500 550
Fig 2 Number of bed days spent as an inpatient during 18 months’ follow-up
of clients with serious mental illness assigned to care by assertive community
treatment team or community mental health team
Table 3 Inpatient service use over 18 months for clients with serious
mental illness assigned to assertive community treatment or to community
mental health team care. Values are numbers (percentages) of clients unless
stated otherwise
Variable
Assertive community
treatment team (n=124)
Community mental
health team (n=119)
Total No of inpatient days:
Mean (SD) 162 (161) 144 (140)
Median (interquartile range) 120 (27-231) 130 (14-215)
No of new admissions:
Mean (SD) 1.0 (1.1) 1.1 (1.4)
Median (interquartile range) 1 (0-2) 1 (0-2)
No of days per admission:
Mean (SD) 65 (91) 52 (66)
Median (interquartile range) 27 (0-95) 27 (0-86)
No of days to discharge if recruited
as inpatient:
n=60 n=55
Mean (SD) 158 (177) 141 (159)
Median (interquartile range) 70 (29-272) 61 (14-215)
Inpatient throughout 7 (6) 3 (30)
Any admission 73 (59) 65 (55)
n=73 n=65
1 admission 39 (32) 31 (26)
2 admissions 23 (19) 17 (14)
>2 admissions 11 (9) 17 (14)
Involuntary admissions 60 (82) 54 (83)
≥1 PICU admissions 17 (23) 16 (25)
≥1 MSU admissions 4 (<1) 1 (<1)
PICU=psychiatric intensive care unit; MSU=medium secure unit.
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One important limitation of the study was its non-blindness,
although this might have been expected to lead the assertive
community treatment teams to resist more admissions than the
community mental health teams. Likewise, interviewer bias
might have been expected to increase differences between the
groups. That this was not the case supports the validity of our
findings. A second limitation was the response rate for follow-up
interviews at which secondary outcome data on symptoms,
needs, quality of life, and satisfaction were collected. However,
use of a combination of participant and staff rated measures
reduced both interviewer and non-response bias as data from
staff rated measures on clinical and social function, substance
misuse, compliance with drugs, and adverse events were available
for all participants.
The number of days spent in hospital was similar for both
groups and our primary hypothesis was therefore not
supported. We analysed multiple secondary outcomes of which
two achieved nominal significance. Any adjustment for multiple
analyses would reduce the degree of statistical significance. Bear-
ing this in mind, our results suggest that patients receiving asser-
tive community treatment were better engaged in terms of both
quantity and quality of contact with staff, and fewer clients were
lost to follow-up. In addition, greater satisfaction with services
was reported by clients assigned to assertive community
treatment who agreed to be interviewed. These findings suggest
that the assertive community treatment approach may be more
acceptable to this difficult to engage client group than the stand-
ard community mental health team model. This was not,
however, associated with any improvement in social or clinical
function.
In the context of the UK government’s national policy of
strongly encouraging the implementation of assertive commu-
nity treatment,13 14 our results require further examination. Inpa-
tient mental health services in inner cities are already operating
with high admission thresholds, most patients being detained
under the Mental Health Act 1983.32 Interventions that aim to
prevent or reduce admissions are therefore unlikely to succeed. It
may also be that the approach of community mental health
teams, particularly in inner cities, already incorporates features
of assertive community treatment such as relatively low case
loads, dedicated inpatient beds, similar staffing structures, and
home visits.12
Another possibility is that because the assertive community
treatment teams in our study were new, lack of experience may
have reduced their effectiveness. Finally, an 18 month follow-up
may not have been long enough to measure positive change:
over a longer follow-up, greater engagement and satisfaction
might have an effect on other outcomes.
Our findings should encourage policy makers and service
planners to consider whether improved engagement and
satisfaction for recipients of assertive community treatment
justify its implementation. Further investigation is needed as to
whether the elements of such treatment that enhance
engagement with services could be incorporated effectively into
the work of community mental health teams. Certainly this can-
not be achieved through a simple reduction in case load.9 10
Assertive community treatment is gaining popularity in Europe,
but our results suggest that it cannot be assumed to be preferable
to well developed generic community mental health teams.
Table 4 Secondary outcomes at 18 months for clients with serious mental
illness assigned to assertive community treatment or to community mental
health team care. Values are numbers (percentages) of clients unless stated
otherwise
Variable
Assertive
community
treatment team
Community
mental
health team
Mean difference
(95% CI) P value
n=91 n=75
Mean (SD) symptoms
(EBPRS)
32.9 (9.0) 33.5 (8.6) −0.6 (−3.3 to 2.1) 0.66
Mean (SD) unmet
needs (CANSAS)
3.3 (2.7) 3.4 (2.9) −0.1 (−1.0 to 0.7) 0.76
Mean (SD) satisfaction
(CSQ)
77.2 (20.0) 70.0 (20.6) 7.14 (0.9 to 13.4) 0.03
n=91 n=67
Mean (SD) quality of
life (MANSA)
4.5 (1.0) 4.4 (0.9) 0.1 (−0.2 to 0.4) 0.56
n=124 n=115
Mean (SD) social
function (LSP)
119 (16.4) 115 (19.7) 4.3 (−0.3 to 8.9) 0.07
Mean (SD) total score
(HoNOS)
8.6 (4.8) 9.0 (5.9) −0.4 (−1.8 to 1.0) 0.56
Mean (SD) influences
on medication
(RoMI): compliance
6.7 (2.6) 6.1 (2.5) 0.6 (−0.6 to 1.2) 0.07
Mean (SD) influences
on medication
(RoMI):
non-compliance
10.8 (4.3) 11.4 (3.8) −0.7 (−1.7 to 0.4) 0.20
Mean (SD) engagement
(HEAS)*
9.1 (3.3) 8.0 (3.8) 1.1 (0.1 to 1.9) 0.03
n=124 n=115
Lost to follow-up 2 (2) 10 (8) 5.96† 0.01
Serious incidents in
past 18 months:
Homeless 12 (10) 16 (14) 1.03† 0.31
Violence‡ 21 (17) 14 (12) 1.08† 0.30
Deliberate self
home§
10 (8) 13 (11) 0.72† 0.40
Arrested 23 (19) 25 (22) 0.38† 0.54
Forensic¶ 9 (7) 6 (5) 0.22† 0.64
Prison 3 (2) 4 (3) 0.24† 0.63
Substance misuse:
Alcohol 25 (20) 21 (18) 0.14† 0.71
Illicit drugs 29 (23) 25 (22) 0.64† 0.42
*Includes participants who disengaged completely and were out of contact with services
therefore assertive community treatment n=124, community mental health care n=119.
†2 tests.
‡Victim required hospital treatment.
§Includes participants who committed suicide: one assigned to assertive community
treatment (total n=125) and three assigned to community mental health care (total n=118).
¶Contact with forensic psychiatric services. What is already known on this topic
Assertive community treatment is one of the most widely
researched mental health service interventions
International studies have shown positive reductions in
length and frequency of admissions
UK studies of other models of intensive community mental
health care have found no advantage over usual care yet
assertive community treatment has been implemented
nationally
What this study adds
Assertive community treatment had no benefit over usual
community mental health team care for inpatient
admissions and clinical or social outcomes
Satisfaction and engagement with services may be greater
for recipients of assertive community treatment
Research
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